The authors established an AAV/HBV mouse model and observed significant dose-dependent reduction in HBsAg and HBV DNA levels for both the medium-dose and highdose groups. The immunohistochemical staining data showed dose-dependent reduction in HBsAg expression in the liver, with high-dose group exhibiting minimal positive expression.
Countstar Connection
Cell numbers were measured in the study's cell samples with Countstar (model not specified) during quality assessment in the 2025 Acta naturae study.
